Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Loss of p53 and c-myc Overrepresentation in Stage T2-3N1-3M0 Prostate Cancer are Potential Markers for Cancer Progression

1 Jan 2002

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Cancer, Lipids, and Metabolism
Share to Prostate Cancer Treatment and Research

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 11796839
DOI: 10.1038/modpathol.3880487

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Loss of p53 and c-myc Overrepresentation in Stage T2-3N1-3M0 Prostate Cancer are Potential Markers for Cancer ProgressionPMID 11796839Read ↗

Patterns of indolence in prostate cancer (Review)Semantic proximity Read ↗

Combined TP53 and RB1 Loss Promotes Prostate Cancer Resistance to a Spectrum of Therapeutics and Confers Vulnerability to Replication StressSemantic proximity Read ↗

Alterations of p53 are common in early stage prostate cancer.Semantic proximity Read ↗

N-Myc Drives Neuroendocrine Prostate Cancer Initiated from Human Prostate Epithelial CellsSemantic proximity Read ↗

Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesisSemantic proximity Read ↗

Comprehensive assessment of TMPRSS2 and ETS family gene aberrations in clinically localized prostate cancerSemantic proximity Read ↗

TP53 missense mutation is associated with increased tumor-infiltrating T cells in primary prostate cancerSemantic proximity Read ↗

KCNMA1 gene amplification promotes tumor cell proliferation in human prostate cancerSemantic proximity Read ↗

High burden of copy number alterations and c-MYC amplification in prostate cancer from BRCA2 germline mutation carriersSemantic proximity Read ↗

MCM7 amplification and overexpression are associated with prostate cancer progressionSemantic proximity Read ↗

APOBEC3B-driven mutations negatively regulated by P53 promote tumor progression and immunosuppressive microenvironment in prostate cancer.Semantic proximity Read ↗

A multiplatform approach identifies miR-152-3p as a common epigenetically regulated onco-suppressor in prostate cancer targeting TMEM97Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.